Medicare Enrolled
Dr. David Spector, MD
Medical Oncology · Moline, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Spector from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Spector?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Spector
Dr. David Spector is a medical oncology specialist in Moline, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Spector performed 1,832 Medicare services across 735 unique beneficiaries.
Between the years covered by Open Payments, Dr. Spector received a total of $13,785 from 71 pharmaceutical and/or device companies across 417 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Spector is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 27% volume in IL
$13,785 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,832
Medicare services
Top 27% in IL for medical oncology
735
Unique beneficiaries
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~92 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,599 | $67 | $224 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
86 | $95 | $344 |
| New patient office visit, complex (60-74 min) | 58 | $135 | $428 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
38 | $46 | $150 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
28 | $110 | $302 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
23 | $24 | $90 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,785
Total received (2018-2024)
Avg $1,969/year across 7 years
Top 24% in IL for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
71
Companies
417
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,739 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$46 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,135
2023
$1,805
2022
$2,443
2021
$1,307
2020
$914
2019
$2,278
2018
$903
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$451
Myriad Genetic Laboratories, Inc.
$378
AstraZeneca Pharmaceuticals LP
$337
Novartis Pharmaceuticals Corporation
$314
Daiichi Sankyo Inc.
$294
Takeda Pharmaceuticals U.S.A., Inc.
$244
PFIZER INC.
$168
Stemline Therapeutics Inc.
$153
SOBI, INC
$145
BeiGene USA, Inc.
$144
E.R. Squibb & Sons, L.L.C.
$144
Genentech USA, Inc.
$142
ABBVIE INC.
$138
Genmab U.S., Inc.
$111
Merck Sharp & Dohme LLC
$91
Gilead Sciences, Inc.
$79
Lilly USA, LLC
$78
Astellas Pharma US Inc
$73
JAZZ PHARMACEUTICALS INC.
$71
Exelixis Inc.
$67
GENZYME CORPORATION
$63
SERVIER PHARMACEUTICALS LLC
$58
Bayer Healthcare Pharmaceuticals Inc.
$56
PharmaEssentia USA Corporation
$55
Eisai Inc.
$54
CATALYST PHARMACEUTICALS, INC.
$31
TAIHO ONCOLOGY, INC.
$30
RECORDATI_RARE_DISEASES_INC.
$23
Ipsen Biopharmaceuticals, Inc
$21
Octapharma USA, Inc.
$21
Adaptive Biotechnologies Corporation
$19
SUN PHARMACEUTICAL INDUSTRIES INC.
$19
Deciphera Pharmaceuticals Inc.
$17
Mirati Therapeutics, Inc.
$16
Alexion Pharmaceuticals, Inc.
$16
Acrotech Biopharma Inc.
$14
Top 3 companies account for 28.2% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,501
Daiichi Sankyo Inc.
$1,154
Novartis Pharmaceuticals Corporation
$851
Genentech USA, Inc.
$809
E.R. Squibb & Sons, L.L.C.
$788
GENZYME CORPORATION
$775
Janssen Biotech, Inc.
$736
Lilly USA, LLC
$709
BeiGene USA, Inc.
$523
Amgen Inc.
$419
Myriad Genetic Laboratories, Inc.
$405
Takeda Pharmaceuticals U.S.A., Inc.
$376
Seagen Inc.
$291
Jazz Pharmaceuticals Inc.
$274
JAZZ PHARMACEUTICALS INC.
$267
PFIZER INC.
$252
Merck Sharp & Dohme Corporation
$213
Gilead Sciences, Inc.
$200
Eisai Inc.
$188
Stemline Therapeutics Inc.
$170
SOBI, INC
$145
Mirati Therapeutics, Inc.
$144
ABBVIE INC.
$138
Ipsen Biopharmaceuticals, Inc
$138
ADC Therapeutics America, Inc.
$134
Merck Sharp & Dohme LLC
$132
HealthMyne, Inc.
$132
G1 Therapeutics, Inc.
$117
Astellas Pharma US Inc
$114
Incyte Corporation
$114
Genmab U.S., Inc.
$111
PUMA BIOTECHNOLOGY, INC.
$110
GlaxoSmithKline, LLC.
$110
AVEO Pharmaceuticals, Inc.
$109
AbbVie Inc.
$102
Exelixis Inc.
$102
PharmaEssentia USA Corporation
$74
Cardinal Health 108, LLC
$63
Verastem, Inc.
$61
SERVIER PHARMACEUTICALS LLC
$58
Bayer Healthcare Pharmaceuticals Inc.
$56
TESARO, Inc.
$36
Karyopharm Therapeutics Inc.
$36
Janssen Pharmaceuticals, Inc
$32
Alexion Pharmaceuticals, Inc.
$32
Celgene Corporation
$32
CATALYST PHARMACEUTICALS, INC.
$31
TAIHO ONCOLOGY, INC.
$30
Clovis Oncology, Inc.
$28
Apellis Pharmaceuticals, Inc.
$23
RECORDATI_RARE_DISEASES_INC.
$23
Agios Pharmaceuticals, Inc.
$21
Octapharma USA, Inc.
$21
EISAI INC.
$20
MorphoSys, US Inc.
$19
Adaptive Biotechnologies Corporation
$19
SUN PHARMACEUTICAL INDUSTRIES INC.
$19
ImmunoGen, Inc.
$18
EMD Serono, Inc.
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
Deciphera Pharmaceuticals Inc.
$17
Pharmacyclics LLC, An AbbVie Company
$15
Shire North American Group Inc
$15
Acrotech Biopharma Inc.
$14
Array BioPharma Inc.
$13
Taiho Oncology, Inc.
$13
Rigel Pharmaceuticals, Inc.
$12
Mylan Institutional Inc.
$12
Helsinn Therapeutics (U.S.), Inc.
$11
Sysmex Inostics Inc
$11
Bayer HealthCare Pharmaceuticals Inc.
$11
Top 3 companies account for 25.4% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AKYNZEO · ALIMTA · ALUNBRIG · Alecensa · Aliqopa · Avastin · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRUKINSA · Bavencio · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Elahere · Empaveli · Enhertu · Epkinly · Erleada · FIRDAPSE · FOTIVDA · FRUZAQLA · Fabhalta · Fulphila · GAZYVA · HYQVIA · HealthMyne · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INVOKANA · Imbruvica · Inrebic · JADENU · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MYRISK · NERLYNX · NINLARO · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPDIVO · OPDUALAG · Odomzo · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PROSTATE CANCER - DISEASE · Padcev · Perjeta · Pomalyst · REBLOZYL · ROZLYTREK · RYBREVANT · RYDAPT · Rituxan · Rubraca · SARCLISA · SCEMBLIX · SYLVANT · Stivarga · TAGRISSO · TASIGNA · TAXOTERE · TECENTRIQ · TIBSOVO · TUKYSA · Tavalisse · Tazverik · Tecentriq · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VPRIV · VYXEOS · Venclexta · Voranigo · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xospata · Xtandi · ZEJULA · ZEPZELCA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Medical oncologists within 10 mi
3
Per 100K population
2.1
County median income
$66,768
Nearest hospital
GENESIS HLTH SYSTEM DBA GENESIS MDL CTR-ILLINI
4.1 mi
4.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Spector is a clinical cardiology specialist, with above-average Medicare volume (top 27% in IL), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Spector experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Spector performed 1,599 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Spector receive payments from pharmaceutical companies?
Yes. Dr. Spector received a total of $13,785 from 71 companies across 417 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Spector's costs compare to other medical oncologists in Moline?
Dr. Spector's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Spector) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Moline
Browse medical oncologists in Moline ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in IL
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in IL
Which IL medical oncologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology